Y. Barenholz, Doxil®-the first FDA-approved nano-drug: from an idea to a product, in: D. Peer (Ed.), Handbook of Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications, Pan Stanford Publishing, Singapore, 2012, pp. 335-398.
A. Gabizon, A. Meshorer, Y. Barenholz, Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration, J. Natl. Cancer Inst. 77 (1986) 459-469.
A. Gabizon, D. Goren, A. Ramu, Y. Barenholz, Design, characterization and antitumor activity of adriamycin-containing phospholipid vesicles, in: G. Gregoriadis, J. Senior, G. Poste (Eds.), Targeting of Drugs with Synthetic Systems, Plenum, London, 1986, pp. 229-238.